Sixth Element Capital is currently managing the £70m CRT Pioneer Fund (CPF) to create the future of cancer therapy and diagnosis.
Investment Type: Venture Capital
Mentions in press and media 2
| Date | Title | Description | Source |
| 16.11.2017 | NeoPhore Raises £3M in Funding | NeoPhore Ltd, a spin out from Cambridge, UK – based PhoreMost Ltd., focused on the discovery and dev... | finsmes.co... |
| 09.04.2012 | EIF and Cancer Research Technology to Create £50M Investment... | European Investment Fund and Cancer Research Technology (CRT), Cancer Research UK’s commercial arm, ... | finsmes.co... |